在移植后慢性肝炎的初次诊断时间中位数为15.25个月。
CH was first diagnosed at a median of 15.25 months after transplantation.
治疗时间中位数在索拉非尼组为23周，在安慰剂组为19周。
Treatment duration was a median of 23 weeks in the sorafenib group and 19 weeks in the placebo group.
估计的潜伏期中位数为8天，从出现腹泻到发生溶血性尿毒症综合征的时间中位数为5天。
The estimated median incubation period was 8 days, with a median of 5 days from the onset of diarrhea to the development of the hemolytic-uremic syndrome.
对于测试样本低于25以下时，几何平均值比中位数能更好的报告最佳任务完成时间中间值。
The Geometric Mean works better than the median for reporting the best middle task time for sample sizes less than 25.
对于测试样本低于25以下时，几何平均值比中位数能更好的报告最佳任务完成时间中间值。
The Geometric Mean works better than the median for reporting the best middle task time for sample sizes less than 25.
应用推荐